Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 21/04/2026
ORCA Goes Public: HKUST and UTS Researchers Release a Market Risk Framework Built on Network Science21/04/2026
Intel’s Struggles Amidst the AI Revolution A 54% DeclineBy News Team24/10/2024 The rapid ascension of artificial intelligence in the tech sector has not heralded success for every company involved. For Intel, the last five years have marked…
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach 21/04/2026
